Skip to main content
Journal of Immunology Research logoLink to Journal of Immunology Research
. 2017 Nov 1;2017:6073961. doi: 10.1155/2017/6073961

Corrigendum to “The Controversial C5a Receptor C5aR2: Its Role in Health and Disease”

Ting Zhang 1, Malgorzata A Garstka 1, Ke Li 1,
PMCID: PMC5687145  PMID: 29226158

In the article titled “The Controversial C5a Receptor C5aR2: Its Role in Health and Disease” [1], there was an error in Table 4, where Jun/fos-A8△71–73 should be corrected to A8△71–73. The corrected table is as follows:

Table 4.

C5aR2 agonists and antagonists.

Ligand Specificity Function Refs
Jun/fos-A8
A8△71–73
C5 mutant peptides
Human and murine C5aR1 and C5aR2 Antagonists—block binding of C5a and C5a
des Arg to C5aRs
[51]
P32, P59—C terminal peptides of C5a hC5aR2 Agonists—strongly stimulate the association of hC5aR2 with β-arrestin 2 [21, 127]
LukS-PV—protein from S. aureus Human and rabbit C5aR1
Human, macaque, and rabbit C5aR2
Antagonist of C5a-induced activation of neutrophils [48, 128]
HIgCB—protein complex from S. aureus Human, macaque, rabbit, and cow C5aRs Antagonist of C5a-induced activation of neutrophils [128, 129]

References

  • 1.Zhang T., Garstka M. A., Li K. The controversial C5a receptor C5aR2: its role in health and disease. Journal of Immunology Research. 2017;2017:16. doi: 10.1155/2017/8193932.8193932 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Immunology Research are provided here courtesy of Wiley

RESOURCES